thrombin receptor peptide sfllrnp has been researched along with dabigatran in 1 studies
| Studies (thrombin receptor peptide sfllrnp) | Trials (thrombin receptor peptide sfllrnp) | Recent Studies (post-2010) (thrombin receptor peptide sfllrnp) | Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) |
|---|---|---|---|---|---|
| 92 | 10 | 29 | 3,887 | 261 | 3,490 |
| Protein | Taxonomy | thrombin receptor peptide sfllrnp (IC50) | dabigatran (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.7 | |
| Prothrombin | Homo sapiens (human) | 0.0046 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 8.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doerner, A; Friebel, J; Hassanein, A; Kränkel, N; Landmesser, U; Rauch, U; Steffens, D; Witkowski, M | 1 |
1 other study(ies) available for thrombin receptor peptide sfllrnp and dabigatran
| Article | Year |
|---|---|
Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?
Topics: Aged; Anticoagulants; Antithrombins; Blood Platelets; Dabigatran; Female; Humans; Male; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thrombosis | 2017 |